Getting to the "Heart" of Cardiac Disease by Decreasing Mitochondrial Iron.
Getting to the "Heart" of Cardiac Disease by Decreasing Mitochondrial Iron.
复制标题
DOI：
10.1161/circresaha.116.309746
复制
发表时间：
2016-11-11
影响因子：
20.1
通讯作者：
Ardehali H
中科院分区：
文献类型：
--
作者：
Chang HC;Shapiro JS;Ardehali H
铁螯合物而不是补充剂对心脏病患者有益。因此，应该致力于开发能够靶向线粒体铁的铁螯合剂。
Iron chelation rather than supplementation would be beneficial to patients with heart diseases. More effort should be devoted to the development of iron chelators that could target mitochondrial iron.